Rigel to Present at the Jefferies Global Healthcare Conference
Rigel Pharmaceuticals (Nasdaq: RIGL), a commercial stage biotechnology company specializing in hematologic disorders and cancer treatments, has announced its participation in the upcoming Jefferies Global Healthcare Conference. CEO Raul Rodriguez will deliver a company overview on June 4, 2025, at 12:50 p.m. ET in New York. The presentation will be accessible via live webcast through Rigel's Investor Relations website.
Founded in 1996 and headquartered in South San Francisco, Rigel focuses on developing novel therapies for patients with blood disorders and cancer. Interested parties can access the presentation through www.rigel.com.
Rigel Pharmaceuticals (Nasdaq: RIGL), un'azienda biotecnologica in fase commerciale specializzata in disturbi ematologici e trattamenti oncologici, ha annunciato la sua partecipazione alla prossima Jefferies Global Healthcare Conference. Il CEO Raul Rodriguez presenter脿 una panoramica aziendale il 4 giugno 2025 alle 12:50 ET a New York. La presentazione sar脿 disponibile in diretta streaming sul sito delle Relazioni con gli Investitori di Rigel.
Fondata nel 1996 e con sede a South San Francisco, Rigel si dedica allo sviluppo di terapie innovative per pazienti con malattie del sangue e cancro. Gli interessati potranno seguire la presentazione su www.rigel.com.
Rigel Pharmaceuticals (Nasdaq: RIGL), una empresa biotecnol贸gica en etapa comercial especializada en trastornos hematol贸gicos y tratamientos contra el c谩ncer, ha anunciado su participaci贸n en la pr贸xima Jefferies Global Healthcare Conference. El CEO Raul Rodriguez ofrecer谩 una visi贸n general de la empresa el 4 de junio de 2025 a las 12:50 p.m. ET en Nueva York. La presentaci贸n estar谩 disponible en transmisi贸n en vivo a trav茅s del sitio web de Relaciones con Inversionistas de Rigel.
Fundada en 1996 y con sede en South San Francisco, Rigel se enfoca en desarrollar terapias novedosas para pacientes con trastornos sangu铆neos y c谩ncer. Los interesados podr谩n acceder a la presentaci贸n en www.rigel.com.
Rigel Pharmaceuticals (雮橃姢雼�: RIGL)鞚� 順堨暋 歆堩櫂 氚� 鞎� 旃橂毳� 鞝勲鞙茧 頃橂姅 靸侅梾 雼硠鞚� 靸濍獏瓿淀暀 須岇偓搿�, 雼り皜鞓る姅 Jefferies Global Healthcare Conference鞐� 彀胳棳頃� 瓴冹瀯鞚� 氚滍憸頄堨姷雼堧嫟. CEO Raul Rodriguez電� 2025雲� 6鞗� 4鞚� 鞓ろ泟 12鞁� 50攵�(霃欕秬鞁滉皠) 雺挫殨鞐愳劀 須岇偓 臧滌殧毳� 氚滍憸頃� 鞓堨爼鞛呺媹雼�. 氚滍憸電� Rigel 韴瀽鞛� 甏�瓿� 鞗轨偓鞚错姼毳� 韱淀暣 靸濎瓿勲 鞁滌箔頃� 靾� 鞛堨姷雼堧嫟.
1996雲勳棎 靹る霅橃柎 靷毎鞀� 靸岉攧霝�鞁滌姢旖旍棎 氤胳偓毳� 霊� Rigel鞚� 順堨暋 歆堩櫂 氚� 鞎� 頇橃瀽毳� 鞙勴暅 順侅嫚鞝侅澑 旃橂氩� 臧滊皽鞐� 歆戩頃橁碃 鞛堨姷雼堧嫟. 甏�鞁� 鞛堧姅 攵勲摛鞚� www.rigel.com鞐愳劀 氚滍憸毳� 鞁滌箔頃� 靾� 鞛堨姷雼堧嫟.
Rigel Pharmaceuticals (Nasdaq : RIGL), une soci茅t茅 biotechnologique en phase commerciale sp茅cialis茅e dans les troubles h茅matologiques et les traitements contre le cancer, a annonc茅 sa participation 脿 la prochaine Jefferies Global Healthcare Conference. Le PDG Raul Rodriguez pr茅sentera un aper莽u de l'entreprise le 4 juin 2025 脿 12h50 ET 脿 New York. La pr茅sentation sera accessible en direct via un webcast sur le site des relations investisseurs de Rigel.
Fond茅e en 1996 et bas茅e 脿 South San Francisco, Rigel se concentre sur le d茅veloppement de th茅rapies innovantes pour les patients atteints de troubles sanguins et de cancer. Les int茅ress茅s pourront acc茅der 脿 la pr茅sentation sur www.rigel.com.
Rigel Pharmaceuticals (Nasdaq: RIGL), ein biotechnologisches Unternehmen in der kommerziellen Phase, das sich auf h盲matologische Erkrankungen und Krebstherapien spezialisiert hat, hat seine Teilnahme an der bevorstehenden Jefferies Global Healthcare Conference angek眉ndigt. CEO Raul Rodriguez wird am 4. Juni 2025 um 12:50 Uhr ET in New York einen Unternehmens眉berblick pr盲sentieren. Die Pr盲sentation wird live 眉ber die Investor-Relations-Website von Rigel als Webcast verf眉gbar sein.
Das 1996 gegr眉ndete Unternehmen mit Hauptsitz in South San Francisco konzentriert sich auf die Entwicklung neuartiger Therapien f眉r Patienten mit Blutkrankheiten und Krebs. Interessierte k枚nnen die Pr盲sentation 眉ber www.rigel.com verfolgen.
- None.
- None.
To access the live webcast or archived recording, visit the Investor Relations section of the company's website at . Please connect to Rigel's website prior to the start of the live webcast to allow for any software downloads.
About Rigel
Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) is a biotechnology company dedicated to discovering, developing and providing novel therapies that significantly improve the lives of patients with hematologic disorders and cancer. Founded in 1996, Rigel is based in
Contact for Investors & Media:
Investors:听
Rigel Pharmaceuticals, Inc.听
650.624.1232听
[email protected]
Media:
David Rosen听
Argot Partners听
646.461.6387
[email protected]听
听
View original content to download multimedia:
SOURCE Rigel Pharmaceuticals, Inc.
FAQ
When is Rigel Pharmaceuticals (RIGL) presenting at the Jefferies Global Healthcare Conference 2025?
Who will be presenting for Rigel Pharmaceuticals at the Jefferies Healthcare Conference?
How can investors access Rigel's presentation at the Jefferies Conference?
What is Rigel Pharmaceuticals' (RIGL) main business focus?
